Connection
Michael Zuscik to Paroxetine
This is a "connection" page, showing publications Michael Zuscik has written about Paroxetine.
|
|
Connection Strength |
|
 |
|
 |
|
0.047 |
|
|
|
-
Carlson EL, Karuppagounder V, Pinamont WJ, Yoshioka NK, Ahmad A, Schott EM, Le Bleu HK, Zuscik MJ, Elbarbary RA, Kamal F. Paroxetine-mediated GRK2 inhibition is a disease-modifying treatment for osteoarthritis. Sci Transl Med. 2021 02 10; 13(580).
Score: 0.047